72 related articles for article (PubMed ID: 25520105)
1. Association of urinary cesium with breast cancer risk.
Qin YC; Tang LY; Su Y; Chen LJ; Su FX; Lin Y; Zhang AH; Ren ZF
Asian Pac J Cancer Prev; 2014; 15(22):9785-90. PubMed ID: 25520105
[TBL] [Abstract][Full Text] [Related]
2. Urinary rubidium in breast cancers.
Su Y; Chen LJ; He JR; Yuan XJ; Cen YL; Su FX; Tang LY; Zhang AH; Chen WQ; Lin Y; Wang SM; Ren ZF
Clin Chim Acta; 2011 Nov; 412(23-24):2305-9. PubMed ID: 21910977
[TBL] [Abstract][Full Text] [Related]
3. Urinary strontium and the risk of breast cancer: a case-control study in Guangzhou, China.
Chen LJ; Tang LY; He JR; Su Y; Cen YL; Yu DD; Wu BH; Lin Y; Chen WQ; Song EW; Ren ZF
Environ Res; 2012 Jan; 112():212-7. PubMed ID: 22172139
[TBL] [Abstract][Full Text] [Related]
4. Urinary titanium and vanadium and breast cancer: a case-control study.
Tang LY; Su Y; He JR; Chen WQ; Su FX; Wu BH; Lin Y; Ren ZF
Nutr Cancer; 2012 Apr; 64(3):368-76. PubMed ID: 22332886
[TBL] [Abstract][Full Text] [Related]
5. [Association between urinary cadmium and clinicopathological characteristics of breast cancer].
Cen YL; Tang LY; Lin Y; Su FX; Wu BH; Ren ZF
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):632-5. PubMed ID: 24314225
[TBL] [Abstract][Full Text] [Related]
6. Urinary lead exposure and breast cancer risk in a population-based case-control study.
McElroy JA; Shafer MM; Gangnon RE; Crouch LA; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2311-7. PubMed ID: 18768499
[TBL] [Abstract][Full Text] [Related]
7. Modified effect of urinary cadmium on breast cancer risk by selenium.
Wei XL; He JR; Cen YL; Su Y; Chen LJ; Lin Y; Wu BH; Su FX; Tang LY; Ren ZF
Clin Chim Acta; 2015 Jan; 438():80-5. PubMed ID: 25149105
[TBL] [Abstract][Full Text] [Related]
8. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
[No Abstract] [Full Text] [Related]
9. Urinary excretion of isoflavonoids and the risk of breast cancer.
Zheng W; Dai Q; Custer LJ; Shu XO; Wen WQ; Jin F; Franke AA
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):35-40. PubMed ID: 9950237
[TBL] [Abstract][Full Text] [Related]
10. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.
Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Grioni S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):729-37. PubMed ID: 20200429
[TBL] [Abstract][Full Text] [Related]
11. Association between cadmium and breast cancer risk according to estrogen receptor and human epidermal growth factor receptor 2: epidemiological evidence.
Strumylaite L; Kregzdyte R; Bogusevicius A; Poskiene L; Baranauskiene D; Pranys D
Breast Cancer Res Treat; 2014 May; 145(1):225-32. PubMed ID: 24692081
[TBL] [Abstract][Full Text] [Related]
12. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E
Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
14. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India.
Dey S; Boffetta P; Mathews A; Brennan P; Soliman A; Mathew A
Int J Cancer; 2009 Oct; 125(7):1663-70. PubMed ID: 19452528
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological study of urinary 6beta-hydroxycortisol to cortisol ratios and breast cancer risk.
Zheng W; Jin F; Dunning LA; Shu XO; Dai Q; Wen WQ; Gao YT; Holtzman JL
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):237-42. PubMed ID: 11303593
[TBL] [Abstract][Full Text] [Related]
16. Urinary phytoestrogens and postmenopausal breast cancer risk.
den Tonkelaar I; Keinan-Boker L; Veer PV; Arts CJ; Adlercreutz H; Thijssen JH; Peeters PH
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591
[TBL] [Abstract][Full Text] [Related]
17. Cadmium exposure and breast cancer risk.
McElroy JA; Shafer MM; Trentham-Dietz A; Hampton JM; Newcomb PA
J Natl Cancer Inst; 2006 Jun; 98(12):869-73. PubMed ID: 16788160
[TBL] [Abstract][Full Text] [Related]
18. Urinary metalloproteinases: noninvasive biomarkers for breast cancer risk assessment.
Pories SE; Zurakowski D; Roy R; Lamb CC; Raza S; Exarhopoulos A; Scheib RG; Schumer S; Lenahan C; Borges V; Louis GW; Anand A; Isakovich N; Hirshfield-Bartek J; Wewer U; Lotz MM; Moses MA
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1034-42. PubMed ID: 18483323
[TBL] [Abstract][Full Text] [Related]
19. Melatonin and breast cancer: a prospective study.
Travis RC; Allen DS; Fentiman IS; Key TJ
J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473
[TBL] [Abstract][Full Text] [Related]
20. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer.
Zhang SM; Willett WC; Selhub J; Hunter DJ; Giovannucci EL; Holmes MD; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2003 Mar; 95(5):373-80. PubMed ID: 12618502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
